JPH0123463B2 - - Google Patents

Info

Publication number
JPH0123463B2
JPH0123463B2 JP59133650A JP13365084A JPH0123463B2 JP H0123463 B2 JPH0123463 B2 JP H0123463B2 JP 59133650 A JP59133650 A JP 59133650A JP 13365084 A JP13365084 A JP 13365084A JP H0123463 B2 JPH0123463 B2 JP H0123463B2
Authority
JP
Japan
Prior art keywords
group
same
alkyl groups
formula
different
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP59133650A
Other languages
English (en)
Japanese (ja)
Other versions
JPS6112662A (ja
Inventor
Takashi Fujikura
Tokuki Ito
Yasuo Isomura
Masaharu Asano
Takaichi Takenaka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Astellas Pharma Inc
Original Assignee
Yamanouchi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Pharmaceutical Co Ltd filed Critical Yamanouchi Pharmaceutical Co Ltd
Priority to JP59133650A priority Critical patent/JPS6112662A/ja
Priority to AU43967/85A priority patent/AU569161B2/en
Priority to PT80714A priority patent/PT80714B/pt
Priority to GR851568A priority patent/GR851568B/el
Priority to ES544647A priority patent/ES8707933A1/es
Priority to SU853915847A priority patent/SU1342413A3/ru
Priority to KR1019850004583A priority patent/KR900005019B1/ko
Priority to MX8511595U priority patent/MX7533E/es
Priority to DE8585304646T priority patent/DE3581967D1/de
Priority to CA000485923A priority patent/CA1300157C/en
Priority to AT85304646T priority patent/ATE61356T1/de
Priority to EP85304646A priority patent/EP0167371B1/en
Publication of JPS6112662A publication Critical patent/JPS6112662A/ja
Priority to ES552335A priority patent/ES8704898A1/es
Priority to ES552336A priority patent/ES8704899A1/es
Priority to US06/908,350 priority patent/US4727082A/en
Priority to CA000571338A priority patent/CA1312085C/en
Priority to MX26687A priority patent/MX26687A/es
Publication of JPH0123463B2 publication Critical patent/JPH0123463B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/82—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Psychiatry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP59133650A 1984-06-28 1984-06-28 ジヒドロピリジン誘導体及びその製法 Granted JPS6112662A (ja)

Priority Applications (17)

Application Number Priority Date Filing Date Title
JP59133650A JPS6112662A (ja) 1984-06-28 1984-06-28 ジヒドロピリジン誘導体及びその製法
AU43967/85A AU569161B2 (en) 1984-06-28 1985-06-21 4-phenyl-1,4-dihydropyridine-3,5-dicarboxylate derivatives
PT80714A PT80714B (en) 1984-06-28 1985-06-26 Process for preparing novel di-hydropyridine compounds having unique pharmacologicals effects
GR851568A GR851568B (enExample) 1984-06-28 1985-06-26
ES544647A ES8707933A1 (es) 1984-06-28 1985-06-27 Un procedimiento para la preparacion de derivados de dihidropiridina.
SU853915847A SU1342413A3 (ru) 1984-06-28 1985-06-27 Способ получени производных 1,4-дигидропиридина
KR1019850004583A KR900005019B1 (ko) 1984-06-28 1985-06-27 디하이드로피리딘 유도체의 제조방법
CA000485923A CA1300157C (en) 1984-06-28 1985-06-28 Dihydropyridine compounds having unique pharmacological effects, and the process for producing them
DE8585304646T DE3581967D1 (de) 1984-06-28 1985-06-28 Dihydropyridin-verbindungen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
MX8511595U MX7533E (es) 1984-06-28 1985-06-28 Procedimiento para preparar derivados de dihidropiridina
AT85304646T ATE61356T1 (de) 1984-06-28 1985-06-28 Dihydropyridin-verbindungen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
EP85304646A EP0167371B1 (en) 1984-06-28 1985-06-28 Dihydropyridine compounds, their production, and pharmaceutical compositions containing them
ES552335A ES8704898A1 (es) 1984-06-28 1986-02-24 Un procedimiento para la preparacion de derivados de dihidropiridina
ES552336A ES8704899A1 (es) 1984-06-28 1986-02-24 Un procedimiento para la preparacion de derivados de dihidropiridina
US06/908,350 US4727082A (en) 1984-06-28 1986-09-17 Dihydropyridine compounds and pharmaceutical compositions containing them
CA000571338A CA1312085C (en) 1984-06-28 1988-07-06 Dihydropiridine compounds having unique pharmacological effects, and the process for producing them
MX26687A MX26687A (es) 1984-06-28 1988-07-20 Procedimiento para la preparar derivados de dehidropiridina.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59133650A JPS6112662A (ja) 1984-06-28 1984-06-28 ジヒドロピリジン誘導体及びその製法

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP31122586A Division JPS62294656A (ja) 1986-12-26 1986-12-26 新規ジヒドロピリジン化合物

Publications (2)

Publication Number Publication Date
JPS6112662A JPS6112662A (ja) 1986-01-21
JPH0123463B2 true JPH0123463B2 (enExample) 1989-05-02

Family

ID=15109748

Family Applications (1)

Application Number Title Priority Date Filing Date
JP59133650A Granted JPS6112662A (ja) 1984-06-28 1984-06-28 ジヒドロピリジン誘導体及びその製法

Country Status (13)

Country Link
US (1) US4727082A (enExample)
EP (1) EP0167371B1 (enExample)
JP (1) JPS6112662A (enExample)
KR (1) KR900005019B1 (enExample)
AT (1) ATE61356T1 (enExample)
AU (1) AU569161B2 (enExample)
CA (2) CA1300157C (enExample)
DE (1) DE3581967D1 (enExample)
ES (3) ES8707933A1 (enExample)
GR (1) GR851568B (enExample)
MX (2) MX7533E (enExample)
PT (1) PT80714B (enExample)
SU (1) SU1342413A3 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8503425D0 (en) * 1985-02-11 1985-03-13 Ici Plc Alkanolamine derivatives
GB8503427D0 (en) * 1985-02-11 1985-03-13 Ici Plc Basic compounds
EP0276552A1 (en) * 1986-12-08 1988-08-03 Yamanouchi Pharmaceutical Co. Ltd. 1,4-dihydropyridine derivatives and their production
CA1312611C (en) * 1987-07-01 1993-01-12 Yamanouchi Pharmaceutical Co., Ltd. Pyridine derivatives, process for production thereof and pharmaceutical composition containing them
GB9102031D0 (en) * 1991-01-30 1991-03-13 Fujisawa Pharmaceutical Co Dihydropyridine compounds,and process for their preparation

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2753946A1 (de) * 1977-12-03 1979-06-13 Bayer Ag 1-n-aryl-1,4-dihydropyridine und ihre verwendung als arzneimittel
US4285955A (en) * 1978-10-31 1981-08-25 Bayer Aktiengesellschaft 1,4-Dihydropyridinecarboxylic acids
NZ201395A (en) * 1981-07-30 1987-02-20 Bayer Ag Pharmaceutical compositions containing 1,4-dihydropyridines and certain of these dihydropyridines
DE3207982A1 (de) * 1982-03-05 1983-09-08 Bayer Ag, 5090 Leverkusen Neue 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihrer verwendung in arzneimitteln
HU197881B (en) * 1982-08-06 1989-06-28 Banyu Pharma Co Ltd Process for producing new carbamoyl-oxy-alkyl-carboxy-lic acid derivatives
US4500527A (en) * 1983-06-22 1985-02-19 Usv Pharmaceutical Corporation Antihypertensive 4[(3-alkylamino-2-hydroxypropyl)-oxyiminomethyl phenyl]-1,4-dihydropyridines
NO854021L (no) * 1984-10-26 1986-04-28 Bayer Ag 1,4-dihydropyridin-hydroksyaminer og fremgangsmaate til fremstilling derav.
GB8503425D0 (en) * 1985-02-11 1985-03-13 Ici Plc Alkanolamine derivatives

Also Published As

Publication number Publication date
ES8704898A1 (es) 1987-04-16
EP0167371A3 (en) 1987-06-16
ES8707933A1 (es) 1987-09-01
ATE61356T1 (de) 1991-03-15
CA1300157C (en) 1992-05-05
PT80714B (en) 1986-12-11
JPS6112662A (ja) 1986-01-21
ES552336A0 (es) 1987-04-16
SU1342413A3 (ru) 1987-09-30
KR860000261A (ko) 1986-01-27
US4727082A (en) 1988-02-23
ES8704899A1 (es) 1987-04-16
DE3581967D1 (de) 1991-04-11
AU569161B2 (en) 1988-01-21
MX7533E (es) 1989-08-15
CA1312085C (en) 1992-12-29
EP0167371A2 (en) 1986-01-08
EP0167371B1 (en) 1991-03-06
ES552335A0 (es) 1987-04-16
PT80714A (en) 1985-07-01
GR851568B (enExample) 1985-11-25
AU4396785A (en) 1986-01-02
MX26687A (es) 1994-03-31
ES544647A0 (es) 1987-09-01
KR900005019B1 (ko) 1990-07-18

Similar Documents

Publication Publication Date Title
US4520025A (en) Bicyclic nitrogen heterocyclic ethers and thioethers, and their pharmaceutical uses
JPS60156671A (ja) ジヒドロピリジン誘導体およびその製造法
JPS6339588B2 (enExample)
EA006237B1 (ru) Производные аминоалкилбензоилбензофурана, способ их получения и содержащие их композиции
US4450115A (en) Amino-alcohol derivatives
IE61901B1 (en) "Substituted 1h-imidazoles"
JPS6330911B2 (enExample)
US5063246A (en) Phenethylamine derivative compositions and use
US4923880A (en) 4,5,6,7-Tetrahydroisothiazolo (4,5-c) pyridine derivatives
PL193438B1 (pl) Pochodna 5-podstawionego-1,2,4-tiadiazolilu, jej zastosowanie i sposób wytwarzania, kompozycja farmaceutyczna, karbotioaminowa pochodna piperazyny i sposób jej wytwarzania
JP2980749B2 (ja) フラン誘導体
JPS6112662A (ja) ジヒドロピリジン誘導体及びその製法
US5198587A (en) Phenethylamine derivatives
EP0257616A2 (en) Dihydropyridine derivates and pharmaceutical composition thereof
JPS62281860A (ja) アルキレンアミノアルキレン　ヘテロ原子基を有するジヒドロ−３，５−ジカルボキシレ−ト
PL191409B1 (pl) Pochodna tiadiazolilopirydazyny, jej zastosowanie i sposób wytwarzania oraz kompozycja farmaceutyczna
US4757080A (en) 1,4-dihydropyridine derivatives
EP0265947B1 (en) Dihydropyridine derivatives, process for their preparation, pharmaceutical composition and use
US4843085A (en) Pyridine derivatives, process for production thereof and pharmaceutical compositions useful as anti-arhytmics
JPH0517907B2 (enExample)
IE51727B1 (en) Pyridine derivatives as immunoregulatory agents
JPH02350B2 (enExample)
JPS5839832B2 (ja) 新規ピラジン化合物の製法
JPH0559107B2 (enExample)
JPH02138257A (ja) １，４―ジヒドロピリジン化合物